Intended for healthcare professionals

  1. News & Views
  2. The new BMJ policy on...
  3. The new BMJ policy on sharing data from drug and device trials
Editorials

The new BMJ policy on sharing data from drug and device trials

BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e7888 (Published 20 November 2012) Cite this as: BMJ 2012;345:e7888

Related articles

BlogTrish Groves: A European tale—data sharing at the EMA
NewsEurope’s drug agency will publish clinical trial data for new products from 2014

See more

Cited by...

  • Mandatory data and code sharing for research published by The BMJ
  • Data-sharing recommendations in biomedical journals and randomised controlled trials: an audit of journals following the ICMJE recommendations
  • Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine
  • Has open data arrived at the British Medical Journal (BMJ)? An observational study
  • Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013
  • The BMJ requires data sharing on request for all trials
  • PCORI's ambitious efforts to promote transparency and dissemination of research findings
  • Advancing the Research Enterprise: Establishing a New Standard Practice for Disseminating Clinical Trial Results to Study Volunteers
  • Reply to W. Read
  • Should journals stop publishing research funded by the drug industry?
  • Editor's reply to Smith
  • Sharing data from clinical trials: where we are and what lies ahead
  • Are clinical trial data shared sufficiently today? No
  • The European Medicines Agency's plans for sharing data from clinical trials
  • Data in trials and their published papers do not always agree, finds analysis
Back to top